# Rizobacter

Companies like Verdesian Life Sciences and Rizobacter (part of Bioceres) dominate the seed treatment and nutrient use efficiency (NUE) space, offering high-concentration inoculants for broad-acre crops.

Source: https://en.bioecon.ru/companies/rizobacter/
Updated: 2026-06-24

- Country: Argentina

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Funding | $26.0 million public offering of Series V corporate bonds in the Argentine market (2021) | https://investors.biocerescrops.com/news/news-details/2021/Bioceres-Crop-Solutions-Subsidiary-Rizobacter-Argentina-S.A.-Completes-26.0-Million-Offering-of-Series-V-Corporate-Bonds/default.aspx |
| Capacity | 50,000 tons per year for micro granulated fertilizers; 7.2 million liters per year for biological products | https://rizobacter.com.ar/es/noticia/rizobacter-inauguro-una-nueva-planta-para-producir-mas-biologicos, https://www.rizobacter.com/en/rizobacter-cifras |
| Certification | ISO 9001:2015, ISO 14001:2015, OHSAS 18001:2007 (Trinorm Certification) | https://rizobacter.com.bo/sites/default/files/pdf/es/new-product-guide-rizobacter-1.pdf, https://rizobacter.com/en/our-commitment, https://www.rizobacter.com/en/who-we-are |
| Regulatory approval | 56 new international registrations obtained from March 2020 to present; registration for Rhizoliq TOP in China (2024) | https://rizobacter.com/node/1240, https://www.knoell.com/en/news/regulatory-registration-of-microbial-fertilizer-in-china-completed-for-long-established, https://www.rizobacter.com/en/noticia/argentinian-company-global-leader-soybean-inoculants |
| Production site | Pergamino, Argentina (including Synertech Industries plant) | https://rizobacter.com.ar/es/noticia/rizobacter-inauguro-una-nueva-planta-para-producir-mas-biologicos, https://www.rizobacter.com/en/rizobacter-cifras, https://www.rizobacter.com/en/who-we-are |
| Headcount | Approximately 620-700 employees globally | https://rizobacter.com.ar/es/noticia/rizobacter-inauguro-una-nueva-planta-para-producir-mas-biologicos, https://www.rizobacter.com/en/who-we-are |
| Revenue | $197.8 million for the fiscal year ended June 30, 2025 | https://www.sec.gov/Archives/edgar/data/1769484/000110465925108999/R37.htm |

Independent sources: investors.biocerescrops.com, knoell.com, sec.gov

## Technologies

- [Nitrogen-fixing microbial inoculants](https://en.bioecon.ru/technology/nitrogen-fixing-microbial-inoculants/)